Nadia Luheshi

1.7k total citations
35 papers, 1.1k citations indexed

About

Nadia Luheshi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Nadia Luheshi has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 20 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Nadia Luheshi's work include Cancer Immunotherapy and Biomarkers (14 papers), Immune cells in cancer (10 papers) and Immunotherapy and Immune Responses (9 papers). Nadia Luheshi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immune cells in cancer (10 papers) and Immunotherapy and Immune Responses (9 papers). Nadia Luheshi collaborates with scholars based in United Kingdom, United States and Singapore. Nadia Luheshi's co-authors include David Brough, Gloria López‐Castejón, Ádám Dénes, Krisztina Kovács, James Giles, James Legg, Roger C. Whitehead, Aleksandr Kirov, Nancy J. Rothwell and Vincent Compan and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Nadia Luheshi

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadia Luheshi United Kingdom	13	547	536	270	88	76	35	1.1k
Myoungsun Son United States	18	675 1.2×	293 0.5×	124 0.5×	96 1.1×	64 0.8×	25	1.1k
Kathrin Weber Germany	12	400 0.7×	908 1.7×	165 0.6×	34 0.4×	165 2.2×	23	1.3k
Pervinder Sagoo United Kingdom	16	840 1.5×	270 0.5×	228 0.8×	29 0.3×	73 1.0×	26	1.3k
Rosanna Mezzapelle Italy	14	317 0.6×	294 0.5×	257 1.0×	49 0.6×	83 1.1×	19	1.0k
Pam Hall Australia	18	560 1.0×	228 0.4×	108 0.4×	59 0.7×	91 1.2×	30	1.0k
Rinat Zaynagetdinov United States	21	783 1.4×	498 0.9×	396 1.5×	97 1.1×	138 1.8×	33	1.8k
Carole Berruyer-Pouyet France	9	287 0.5×	361 0.7×	84 0.3×	163 1.9×	117 1.5×	10	832
Judith F. Ashouri United States	13	461 0.8×	207 0.4×	187 0.7×	42 0.5×	62 0.8×	18	941
Yousuke Murakami Japan	22	570 1.0×	502 0.9×	93 0.3×	25 0.3×	62 0.8×	36	1.3k
Masanao Saio Japan	18	725 1.3×	191 0.4×	360 1.3×	72 0.8×	75 1.0×	34	1.1k

Countries citing papers authored by Nadia Luheshi

Since Specialization

Citations

This map shows the geographic impact of Nadia Luheshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Luheshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Luheshi more than expected).

Fields of papers citing papers by Nadia Luheshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Luheshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Luheshi. The network helps show where Nadia Luheshi may publish in the future.

Co-authorship network of co-authors of Nadia Luheshi

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Luheshi. A scholar is included among the top collaborators of Nadia Luheshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Luheshi. Nadia Luheshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chandana, Sreenivasa R, Ana Ruiz‐Casado, Andrew L. Coveler, et al.. (2025). 2223P First-line (1L) AZD0171 + durvalumab (D) + chemotherapy (CT) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): Phase II study results. Annals of Oncology. 36. S1150–S1151.

Santha, Sreevidya, Man Li, Simon F. Roy, et al.. (2025). Intratumoral IL12 mRNA administration activates innate and adaptive pathways in checkpoint inhibitor-resistant tumors resulting in complete responses. Cancer Immunology Immunotherapy. 74(8). 250–250. 1 indexed citations

Ye, Jian, Shuyang Qin, Angela Hughson, et al.. (2025). Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. Cancers. 17(2). 204–204. 1 indexed citations

Ye, Jian, Shuyang Qin, Angela Hughson, et al.. (2025). Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. Journal for ImmunoTherapy of Cancer. 13(5). e010820–e010820.

Huang, Yue, Jiaqi Yuan, Kathryn Ball, et al.. (2024). Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo. Analytical Chemistry. 96(42). 16525–16533. 9 indexed citations

Penney, Mark, Juliana Candido, Jim Eyles, et al.. (2024). A mechanistic PK/PD model of AZD0171 (anti‐LIF) to support Phase II dose selection. CPT Pharmacometrics & Systems Pharmacology. 13(10). 1670–1681. 2 indexed citations

Krykbaeva, Irina, William Damsky, Meaghan K. McGeary, et al.. (2023). Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance. Cancer Immunology Research. 11(10). 1332–1350. 12 indexed citations

Mele, Deanna A., Neil P. Grimster, Gayathri Bommakanti, et al.. (2023). Abstract 3453: First disclosure of a highly potent and selective HPK1 inhibitor that rescues T cell exhaustion. Cancer Research. 83(7_Supplement). 3453–3453. 3 indexed citations

Santha, Sreevidya, Man Li, Nadia Luheshi, et al.. (2023). 1069 IL-12 mRNA monotherapy is effective in murine tumors resistant to checkpoint inhibition. SHILAP Revista de lepidopterología. A1176–A1176. 1 indexed citations

10.

Candido, Juliana, Gozde Kar, Fabien Garçon, et al.. (2023). 785 mAZD0171 mediated LIF blockade in combination with chemotherapy and PD-L1 inhibition repolarizes macrophages and increases T cell infiltration via CX3CR1-CX3CL1 axis. SHILAP Revista de lepidopterología. A882–A882. 1 indexed citations

11.

Marron, Thomas U., Vivek Subbiah, Omid Hamid, et al.. (2020). 1075TiP MEDI1191, a novel IL-12 mRNA therapy for intratumoral (IT) injection for advanced solid tumours. Annals of Oncology. 31. S730–S730. 1 indexed citations

12.

Tapia, Víctor S., Michael J. Daniels, Pablo Palazón‐Riquelme, et al.. (2019). The three cytokines IL-1β, IL-18, and IL-1α share related but distinct secretory routes. Journal of Biological Chemistry. 294(21). 8325–8335. 66 indexed citations

13.

Luheshi, Nadia, Susannah L. Hewitt, Fabien Garçon, et al.. (2019). Abstract 5017: MEDI1191, a novel IL-12 mRNA therapy for intratumoral injection to promote TH1 transformation of the patient tumor microenvironment. Cancer Research. 79(13_Supplement). 5017–5017. 7 indexed citations

14.

Mullins, Stefanie, John P. Vasilakos, Katharina Deschler, et al.. (2019). Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies. Journal for ImmunoTherapy of Cancer. 7(1). 244–244. 137 indexed citations

15.

Borrok, M. Jack, Nadia Luheshi, Gareth Davies, et al.. (2015). Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding. mAbs. 7(4). 743–751. 58 indexed citations

16.

England, Hazel, Gloria López‐Castejón, Catherine B. Lawrence, et al.. (2014). Zinc depletion regulates the processing and secretion of IL-1β. Cell Death and Disease. 5(1). e1040–e1040. 76 indexed citations

17.

Luheshi, Nadia, Gareth Davies, & James Legg. (2014). Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists. OncoImmunology. 3(2). e27615–e27615. 11 indexed citations

18.

Luheshi, Nadia, et al.. (2013). Abstract 1542: Th1 and Th2 cytokines determine how CD40 activation changes human macrophage function in vitro.. Cancer Research. 73(8_Supplement). 1542–1542. 1 indexed citations

19.

Luheshi, Nadia, James Giles, Gloria López‐Castejón, & David Brough. (2011). Sphingosine regulates the NLRP3‐inflammasome and IL‐1β release from macrophages. European Journal of Immunology. 42(3). 716–725. 77 indexed citations

20.

Luheshi, Nadia, Krisztina Kovács, Gloria López‐Castejón, David Brough, & Ádám Dénes. (2011). Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues. Journal of Neuroinflammation. 8(1). 186–186. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact